Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 482 results for "Cgix"

Cancer Genetics' Proprietary IVD for Cervical Cancer, FHACT(R), Receives CE
SPi World News

Cancer Genetics, Inc. to Report Third Quarter 2014 Financial R...

RUTHERFORD, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today that it will report third quarter 2014 financial results on Monday, November 10, 2014. The Company will ... Industrial Info Financials, 15 hours ago
[x]  

Cancer Genetics (CGIX), Columbia's Azra Raza Enter Research Collaboration

Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9904680 for the
 Town Hall2 weeks ago
[x]  

Cancer Genetics Reaches New 1-Year Low at $7.87 (CGIX)

Cancer Genetics (NASDAQ:CGIX) shares reached a new 52-week low during trading on Monday , reports. The company traded as low as $7.87 and last traded at $8.10, with a volume of 40,097 shares. The stock had previously closed at $8.38. Separately, ...
 American Banking News3 weeks ago Cancer Genetics Hits New 1-Year Low at $8.25 (CGIX)  American Banking News1 month ago

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update

Cancer Genetics, Inc. (CGI) is a pharmaceutical company. The company offers DNA-based cancer diagnostics products and services. Its products include DNA-FISH Probes, CGH Microarrays and Next-Generation Sequencing. CGI's oncology tests and laboratory ...
 Research and Markets1 month ago

Cancer Genetics boosts Medicare coverage for DNA-based cancer Dx

Cancer Genetics (CGI) ($CGIX) isn't making money yet. But the New Jersey-based developer of DNA-based cancer diagnostics closed out its 2014 second quarter with smaller losses, some strategic acquisitions and a biomarker development partnership with ...
 Fierce BioMarkers2 months ago

Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R)

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 30, 2014. Immunomedics, Inc., (Nasdaq:IMMU) announced isactuzumab govitecan (IMMU-132), the Company's proprietary solid-tumor ...
 BioMedReports3 hours ago Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cell Therapy Product Line  TMC Net1 week ago Lipocine Announces Positive Results In Phase 2a Study Of LPCN; Kite Reports Positive Results With Anti-CD19  BioMedReports2 weeks ago FDA Allows Marketing of Test to Identify Five Yeast Pathogens; Atossa Offers Regulatory, Commercial Update on ForeCYTE  TMC Net1 month ago
[x]  

Cleveland Clinic crew identifies possible lung cancer biomarkers

Cleveland Clinic scientists believe they have identified possible blood biomarkers that could help detect lung cancer, based on the alteration of metabolic processes that happens to patients with the disease at various stages. Details of their ...
 Fierce BioMarkers1 week ago

Leading Health Care Stock for Small-Cap Stars is Invivo Therapeutics Hldgs (NVIV) for October 20

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with ...
 Equities.com1 week ago

Boston Therapeutics Inc (BTHE) is Top Small-Cap Star for October 21

Equities.com Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, generated returns of 45.32% in 2013. And this year's list is full of even more small caps potentially poised to make big gains. Here ...
 Equities.com1 week ago Galectin Therapeutics Inc. (GALT) is Top Small-Cap Star for August 27  Equities.com2 months ago

Leading Small-Cap Stars Health Care Stock for October 21 Morning Session is Boston Therapeutics Inc (BTHE)

The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps ...
 Equities.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less